Vanessa Damazio Teich

Formação complementar

Idiomas

Áreas de atuação

Produções bibliográficas

• ANTUNES, HÉLITON S. ; SCHLUCKEBIER, LUCIENE FONTES ; HERCHENHORN, DANIEL ; SMALL, ISABELE A. ; ARAÚJO, CARLOS M.M. ; VIÉGAS, CELIA MARIA PAIS ; RAMPINI, MARIANA P. ; FERREIRA, ELZA M.S. ; DIAS, FERNANDO L. ; TEICH, VANESSA ; TEICH, NELSON ; FERREIRA, CARLOS G. . Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. ORAL ONCOLOGY , v. 52, p. 85-90, 2016.

• TEICH, VANESSA ; PIHA, TONY ; FAHHAM, LUCAS ; SQUIASSI, HALINE BIANCA ; PALONI, EVERTON DE MATOS ; ARAÚJO, DENIZAR VIANNA ; MIRANDA, PAULO . Acute Coronary Syndrome Treatment Costs from the Perspective of the Supplementary Health System. Arquivos Brasileiros de Cardiologia , v. 105, p. 339-344, 2015.

• ASSUNCAO, MURILLO SANTUCCI CESAR ; TEICH, VANESSA ; SHIRAMIZO, SANDRA CHRISTINA PEREIRA LIMA ; ARAÚJO, DENIZART VIANNA ; CARRERA, RENATO MELLI ; SERPA NETO, ARY ; SILVA, ELIEZER . The cost-effectiveness ratio of a managed protocol for severe sepsis. JOURNAL OF CRITICAL CARE , v. 29, p. 692.e1-692.e6, 2014.

• BAHAMONDES, M. VALERIA ; DE LIMA, YURI ; TEICH, VANESSA ; BAHAMONDES, LUIS ; MONTEIRO, ILZA . Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil. CONTRACEPTION , v. 86, p. 244-250, 2012.

• ARTIFON, EVERSON L. A. ; SILVEIRA, EDUARDO B. ; APARICIO, DAYSE ; TAKADA, JONAS ; BARACAT, RENATO ; SAKAI, CHRISTIANO M. ; GARCIA, RUEL T. ; TEICH, VANESSA ; COUTO, DECIO S. . Management of Common Bile Duct Stones in Cirrhotic Patients with Coagulopathy: A Comparison of Supra-Papillary Puncture and Standard Cannulation Technique. DIGESTIVE DISEASES AND SCIENCES , v. 56, p. 1904-1911, 2011.

• ARAÚJO, DENIZAR VIANNA ; TEICH, VANESSA ; PASSOS, ROBERTA BENITEZ FREITAS ; MARTINS, SHEILA CRISTINA OURIQUES . Análise de custo-efetividade da trombólise com alteplase no Acidente Vascular Cerebral. Arquivos Brasileiros de Cardiologia , v. 95, p. 12-20, 2010.

• ARAUJO, DV ; TURA, BR ; BRASILEIRO, AL ; NETO, HL ; PAVÃO, ALB ; TEICH, V. D. . Custo-Efetividade da Trombólise Pré-Hospitalar vs Intra-Hospitalar no Infarto Agudo do Miocárdio.. Arquivos Brasileiros de Cardiologia (Impresso) , v. 90, p. 100-107, 2008.

• TEICH, N ; TEICH, V. D. ; PAVÃO, ALB . Análise Econômica do Uso de Cetuximabe no Tratamento de Pacientes com Carcinoma de Células Escamosas de Cabeça e Pescoço Localmente Avançado.. RSBC. Revista-Sociedades Brasileiras de Câncer (Impresso) , v. 16, p. 21-26, 2007.

• FERNANDES, R. A. ; TEICH, V. D. . Overall Survival (OS) Versus Progression-Free Survival (PFS): Is There A Rational For Replacing One Outcome For The Other?. In: ISPOR 6th Latin America Conference, 2017, São Paulo. Value in Health, 2017. v. 20. p. A863.

• FAHHAM, L. ; UEDA, A. ; TEICH, V. D. . Predicting Dengue Fever Outbursts In Brazil: An Empirical Model Based On Climatic Parameters. In: ISPOR 6th Latin America Conference, 2017, São Paulo. Value in Health, 2017. v. 20. p. A856.

• FERNANDES, R. A. ; SAUBERMAN, M. ; DD, B. ; AMARAL, L. M. ; VASCONCELLOS, J. F. ; SOUZA, C. ; TEICH, V. D. . Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City. In: ISPOR 6th Latin America Conference, 2017, São Paulo. Value in Health, 2017. v. 20. p. A941.

• AMARAL, L. M. ; AMARAL, D. M. ; FERNANDES, R. A. ; MENEZES, L. P. ; CORREA, J. S. ; TEICH, V. D. . Transsexual?s Sex Reassigment Process In Brazilian National Health System: Where Are We?. In: ISPOR 6th Latin America Conference, 2017, São Paulo. Value in Health, 2017. v. 20. p. A904.

• SASSE, A. ; LOPES, G. ; TEICH, V. D. ; FAY, A. ; ABADI, M. ; SCHULTZ, N. ; STEFANI, S. . Number Needed to Treat and Cost Per Clinically Meaningful Outcome of Enzalutamide and Abiraterone Acetate for The Treatment of Metastatic Castration-Resistant Prostate Cancer That Failed Androgen Deprivation Therapy in Brazil. In: ISPOR 19th Annual European Congress, 2016, Viena. Value in Health, 2016. v. 19. p. A722.

• FAHHAM, L. ; AMARAL, L. M. ; TEICH, V. D. ; MACHADO, M. ; SERAFINI, P. . Cost-Utility Analysis of Dimethyl Fumarate as a First Switch Treatment for Relapsing Remitting Multiple Sclerosis in the Brazilian Public Health Care System. In: ISPOR 21st Annual International Meeting, 2016, Washington DC. Value in Health, 2016. v. 19. p. A61.

• ASANO, E. ; TEICH, V. D. ; AMARAL, L. M. ; FERNANDES, R. A. ; FAHHAM, L. . Hospital Readmissions and Mortality Patterns in a Cohort with Heart Failure: 1 Year Follow-Up from the Brazilian Public Healthcare System Database. In: ISPOR 18th Annual European Congress, 2015, Milão. Value in Health, 2015. v. 18. p. A381.

• STEFANI, S. ; SAGGIA, M. ; NAVES, A. ; VASCONCELLOS, J. F. ; TEICH, V. D. . Extended-Release Oxycodone Hydrochloride (Oxycontin®) for Cancer Pain Management: a Cost Analysis from the Brazilian Public and Private Healthcare Systems Perspectives. In: ISPOR 18th Annual European Congress, 2015, Milão. Value in Health, 2015. v. 18. p. A445.

• GULART, A. ; TEICH, V. D. ; OLIVEIRA, R. ; AMARANTE, D. ; ALVES, J. ; MACHADO, M. . Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil. In: ISPOR 5th Latin America Conference, 2015, Santiago. Value in Health, 2015. v. 18. p. ISPOR 5th Latin.

• PEPE, C. ; TEICH, V. D. ; COUTINHO, M. ; ALMEIDA, S. . Romiplostim Cost Per Response In Itp Treatment In the Brazilian Health Care System. In: ISPOR 17th Annual European Congress, 2014, Amsterdam. Value in Health, 2014. v. 17. p. A529.

• TEICH, V. D. ; JUNQUEIRA, M. ; PEPE, C. ; MUSSOLINO, F. ; VAZ, P. . Health Technology Assessment In Brazil: A Technical Analysis. In: ISPOR 19th Annual International Meeting, 2014, Montreal. Value in Health, 2014. v. 17. p. A24.

• MUSSOLINO, F. ; VAZ, P. ; PEPE, C. ; TEICH, V. D. ; JUNQUEIRA, M. . Real World Data: A Tool For Decision Making In Health Care. In: Real World Data: A Tool For Decision Making In Health Care, 2014, Montreal. Value in Health, 2014. v. 17. p. A123.

• COSTA, J. ; LIMOEIRO, A. ; SILVA, F. ; TEICH, V. D. ; MARQUES, S. . Impacto Do Uso Do Microdebridador Nos Desfechos E Custos Nas Cirurgias Endoscópicas Nasais. In: ISPOR 4th Latin America Conference, 2013, Buenos Aires. Value in Health, 2013. v. 16. p. A723.

• ALVES, M. ; TEICH, V. D. ; FAHHAM, L. . Resource use patterns and costs associated with the treatment of myelofibrosis, polycythemia vera and essential trombocythemia in the brazilian public health care system. In: ISPOR 18th Annual International Meeting, 2013, New Orleans. Value in Health, 2013. v. 16. p. A190.

• PEREIRA, M. ; BAHMDOUNI, L. ; PEPE, C. ; TEICH, V. D. . Cost-Effectiveness Analysis of Abiraterone for the Treatment of Advanced Prostate Cancer Under the Brazilian Private Health Care System. In: ISPOR 15th Annual European Congress, 2012, Berlin. Value in Health, 2012. v. 15. p. A424-A425.

• SILVA, F. ; LIMOEIRO, A. ; BIANCO, J. ; SARDENBERG, C. ; TEICH, V. D. ; TEICH, N . Impact of Using a Vessel Sealer System and the Harmonic Scalpel in Hospital Outcomes and Cost of Thyroidectomy Procedures. In: ISPOR 15th Annual European Congress, 2012, Berlin. Value in Health, 2012. v. 15. p. A350.

• CLARK, O. ; TEICH, V. D. . Costs Associated to Treatment of Metastatic HER2 Positive Breast Cancer After Progression to Trastuzumab Under the Perspective of the Brazilian Private Health Care System. In: ISPOR 17th Annual International Meeting, 2012, Washington DC. Value in Health, 2012. v. 15. p. A216.

• PEPE, C. ; TEICH, V. D. ; MOULD, J. . Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil). In: ISPOR 14th Annual European Congress, 2011, Madrid. Value in Health, 2011. v. 14. p. A275-A276.

• BECKER, R. ; TEICH, V. D. ; PEPE, C. . National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and Australia. In: ISPOR 14th Annual European Congress, 2011, Madrid. Value in Health, 2011. v. 14. p. A284.

• SCHIOLA, A. ; SILVA, A. ; SANTONI, N. ; PALADINI, L. ; TEICH, V. D. ; PEPE, C. ; ROCHA, M. . Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison With Enoxaparin Under the Brazilian Private Health Care System Perspective. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A545.

• SCHIOLA, A. ; SILVA, A. ; SANTONI, N. ; PALADINI, L. ; TEICH, V. D. ; PEPE, C. ; ROCHA, M. . Cost-Effectiveness And Budget Impact Analysis Of Rivaroxaban in The Prevention of Thromboembolic Eventsin Patients Performing Hip and Knee Arthroplasty in Comparison With no Treatment Under the Brazilian Private Health Care System Perspective.. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A545.

• TEICH, V. D. ; CHAVES, L. ; BIRNBAUM, H. ; PIKE, C. ; WARYAS, C. ; CIFALDI, M. . Economic Model of Workplace Impacts of Anti-Tnf Therapy for Rheumatoid Arthritis in Brazil. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A563-A564.

• PIHA, T. ; RAMIREZ, M. ; SANCHEZ, A. ; MARIZ, V. ; NEVES, J. ; TEICH, V. D. ; ARAUJO, DV . Estimated Cost of Acute Coronary Syndrome for 2011: Case of Brazil. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A544.

• BAHAMONDES, L. ; BAHAMONDES, V. ; SCHIOLA, A. ; SILVA, A. ; SANTONI, N. ; MOURA, M. ; SALEM, J. ; CLARCK, L. ; TEICH, V. D. . Resource Use And Associated Costs For The Treatment Of Heavy Menstrual Bleeding With Levonorgestrel Releasing Intrauterine System (LNG-IUS) Versus Hysterectomy: The Brazilian Public Healthcare System (SUS) Perspective. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A558.

• SCHIOLA, A. ; SILVA, A. ; SANTONI, N. ; PALADINI, L. ; TEICH, V. D. ; PEPE, C. ; ROCHA, M. . Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Perspective. In: ISPOR 3rd Latin America Conference, 2011, Cidade do México. Value in Health, 2011. v. 14. p. A545.

• CLARK, O. ; TEICH, V. D. ; PEREIRA, M. ; FALEIROS, E. ; CLARK, L. . Costs of Supportive Care (SC) for the Treatment of Myelodisplastic Syndrome (MDS) in Brazil: an Analysis from the Private Payer's Perspective. In: ISPOR 13th Annual European Congress, 2010, Praga. Value in Health, 2010. v. 13. p. A461.

• TEICH, V. D. ; COSTA, A. ; CUNHA, T. ; CLARK, L. . Current Trends in Health Technology Incorporation (HTI) in Brazil: Inside the National Health System's (NHS) Black Box. In: ISPOR 13th Annual European Congress, 2010, Praga. Value in Health, 2010. v. 13. p. A417.

• MARINHO, M. ; SCHIOLA, A. ; PIMENTEL, A. ; SANTONI, N. ; TEICH, V. D. ; CLARK, L. . Interactive Electronic Interfaces (IEI): Bridging the Communication Gap by Translating Economic Analysis Results to Decision Makers Everyday Practice. In: ISPOR 13th Annual European Congress, 2010, Praga. Value in Health, 2010. v. 13. p. A316-A317.

• MUSZBECK, N. ; VIOIX, H. ; MUNIR, U. ; SCHIOLA, A. ; VALDERRAMA, A. ; TEICH, V. D. . Cost-effectiveness analysis of Sorafenib versus best supportive care (BSC) in advanced hepatocellular carcinoma (AHCC): the private health care system perspective in Brazil. In: ISPOR 15th Annual International Meeting, 2010, Atlanta. Value in Health, 2010. v. 13. p. A36.

• MUSZBECK, N. ; MUNIR, U. ; VIOIX, H. ; SCHIOLA, A. ; VALDERRAMA, A. ; TEICH, V. D. . Cost-Effectiveness Analysis of Sorafenib Versus Best Supportive Care (BSC) in advanced hepatocellular carcinoma (AHCC): The Public Health Care System Perspective in Brazil. In: ISPOR 15th Annual International Meeting, 2010, Atlanta. Value in Health, 2010. v. 13. p. A35.

• TEICH, V. D. ; HASHIZUME, C. ; MARINHO, T. ; CHARBONNEAU, C. ; NAVES, A. . Economic Evaluation of Sunitinib vs. Interferon-A and Bevacizumab + Interferon-A in the Treatment of Metastatic Renal Cell Carcinoma (CCRM) ? Brazilian Private Health System Perspective. In: ISPOR 15th Annual International Meeting, 2010, Atlanta. Value in Health, 2010. v. 13. p. A37.

• TEICH, N ; SOUZA, C. ; TEICH, V. D. ; CINTRA, M. ; MUSACCHIO, J. ; VIEIRA, F. . Retrospective cost and outcome analysis of breast cancer patients treated in a Brazilian outpatient cancer center (OCC). In: ISPOR 15th Annual International Meeting, 2010, Atlanta. Value in Health, 2010. v. 13. p. A30.

• TEICH, V. D. ; PASSOS, RBF ; TEICH, N ; CANELLA, M . Cost-effectiveness analysis of lapatinib associated to capecitabine versus capecitabine alone and of trastuzumab associated to capecitabine versus capecitabine alone in the treatment of metastatic breast cancer under the Brazilian private health care system perspective. In: ISPOR 2nd Latin American Conference, 2009, Rio de Janeiro. ISPOR 2nd Latin American Conference, 2009.

• TEICH, V. D. ; PASSOS, RBF ; TEICH, N . Cost minimization analysis of tegafur uracil associated to leucovorin (UFT/LV) versus capecitabine alone for metastatic colorectal cancer under the brazilian public health care system perspective.. In: ISPOR 2nd Latin American Conference, 2009, Rio de Janeiro. ISPOR 2nd Latin American Conference, 2009.

• TEICH, V. D. ; PASSOS, RBF ; VIANNA, D . Cost-effectiveness analysis of thrombolysis with recombinant tissue plasminogen activator (alteplase) for acute ischemic stroke under the brazilian public health care system perspective.. In: ISPOR 2nd Latin American Conference, 2009, Rio de Janeiro. ISPOR 2nd Latin American Conference, 2009.

• TEICH, V. D. ; TAKEMOTO, MLS ; BAHIA, L . Resource use and direct medical costs associated to acromegaly treatment under the Brazilian public healthcare system perspective. In: ISPOR 2nd Latin American Conference, 2009, Rio de Janeiro. ISPOR 2nd Latin American Conference, 2009.

• ABDO FILHO, E. ; TAKEMOTO, M. ; TEICH, V. D. ; QUINTELLA, F. ; FERNANDES, R. A. ; PASSOS, R. ; TEICH, N ; SILVA, A. ; MARQUES, M. ; MOTTOLA JR, J. ; GEBRIM, L. ; PICININI, S. ; SAKANO, M. . Cost Analysis of Hormone Receptor Positive, Advanced Breast Cancer Treatment with Endocrine Therapy versus Chemotherapy in the Brazilian Public Health Care System (BPHS). In: ISPOR 12th Annual European Congress, 2009, Paris. Value in Health, 2009. v. 12. p. A268.

• TEICH, V. D. ; NISKIER, F. ; PIMENTEL, A. ; ALAMEDDINE, M. . Cost-Effectiveness Analysis of Formoterol Associated To Budesonide for Maintenance and Reliever Therapy (Symbicort Smart) Versus Salmeterol Associated To Fluticasone in the Treatment of Moderate to Severe Persistent Asthma under the Brazilian Societal Perspective. In: ISPOR 12th Annual European Congress, 2009, Paris. Value in Health, 2009. v. 12. p. A302.

• FERNANDES, R. A. ; QUINTELLA, F. ; TEICH, V. D. ; CARVALHO, J. ; MOLINARI, M. ; KRAMBEK, M. . Cost-Effectiveness and Budget Impact Analysis of Intra-Articular Sodium Hyaluronate versus Total Arthroplasty in the Treatment of Knee Osteoarthritis under the Brazilian Public Health Care System Perspective. In: ISPOR 12th Annual European Congress, 2009, Paris. Value in Health, 2009. v. 12. p. A437.

• FERNANDES, R. A. ; QUINTELLA, F. ; TEICH, V. D. . Cost-Effectiveness Analysis of Dabigatran Etexilate versus Enoxaparin for the Prevention of Venous Thromboembolism after Total Hip Replacement under the Brazilian Public Health Care System Perspective. In: ISPOR 2nd Latin America Conference, 2009, Rio de Janeiro. Value in Health, 2009. v. 12. p. A502.